Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 5OTHER_GOV 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Neoplasms 1Brain Neoplasms 1

Interventions

Drug Therapy 4pembrolizumab 3Thermography 2Surveys and Questionnaires 2Standard of Care 2Quality of Life 2Preoperative Exercise 2Nivolumab 2Moxibustion 2Hematologic Tests 2Cyclophosphamide 2Chemoradiotherapy 2vandetanib 1sinovac COVID-19 vaccine 1lenvatinib 1ibrutinib 1fludarabine 1encorafenib 1durvalumab 1binimetinib 1beta Carotene 1avelumab 1atezolizumab 1Zoledronic Acid 1Zinc 1Vitamin E 1Vascular Access Devices 1Validation Studies as Topic 1Urination 1Ultraviolet Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Neoplasms × Mental Status and Dementia Tests × Clear all
NCT04324450 2025-09-04

IMPALA

Institut National de la Santé Et de la Recherche Médicale, France

Phase NA Completed
60 enrolled
CNS

Brain Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡